The new tests could help detect malaria in cases where plasmodium parasites carry gene deletions impacting traditional rapid diagnostics.

The firm's collaborators presented research at AACR showing an association between ctDNA positivity and lack of pathologic ...

SAN DIEGO – With an enhanced version of its flagship pancreatic cancer assay now available and multiple studies underway for its multi-cancer early detection test, ClearNote Health is advancing its ...

With the next PAMA data collection period starting in May, reporting by hospital labs in particular will be essential, but their level of participation remains uncertain.

The tests use AI-powered algorithms to analyze digital histopathology images, along with patient clinical data.

At AACR, Guardant Health and a Japanese group showcased data on machine learning models that predict the tissue of origin in cancers of unknown primary.

NEW YORK — Solvd Health said on Tuesday that it has received approval from the US Food and Drug Administration to offer its AvertD pharmacogenomic test for opioid use disorder (OUD) using blood ...

The Utrecht, Netherlands-based company recently closed a $70 million funding round and published trial results showing its technology's equivalence to manual blood collection.

Last week, readers were most interested in a story about Roche expanding the cancer testing portfolio of subsidiary Foundation Medicine by buying Saga Diagnostics.

Pathologists at academic medical centers are using intentional change-management strategies to overcome some intangible barriers digital uptake.